– PBGENE-HBV preclinical data reinforce safety profile and potential to deliver a functional cure for chronic hepatitis B, supporting advancement into first-in-human clinical study – – Phase 1 dose ...
CARLSBAD, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today ...
A preclinical study led by the Smidt Heart Institute at Cedars-Sinai challenges the assumption that blocking the NCX1 protein, which regulates calcium levels in cells, is more effective than ...
The pharmaceutical industry has long operated on a one-size-fits-all model, developing drugs primarily tested on, and thus best suited for, people of European descent. This approach ignores — and ...
In a preclinical study, Cedars-Sinai investigators found that boosting angiotensin converting enzyme (ACE) in key immune cells called microglia in the brain helped protect the brains of specially bred ...
The iNSiGHT DXA system is a cutting-edge in vivo Dual Energy X-Ray Absorptiometry (DXA/DEXA) technology intended for preclinical studies. It offers a comprehensive solution for assessing a wide range ...
Animal models are established, important tools for preclinical safety and efficacy testing. Companies are advancing more “humanized” models to better reflect human responses, while at the same time ...
A preclinical study by HSS investigators found that earlier anterior cruciate ligament (ACL) reconstruction led to lower immune cell activity, less inflammation and fewer joint changes associated with ...
The report concludes that BPC-157 remains an active area of scientific inquiry within orthopedic research, gastrointestinal integrity studies, and neurological tissue repair models. The publication ...
Fractyl Health, Inc. announced promising preclinical data for its Rejuva Smart GLP-1 pancreatic gene therapy at the American Diabetes Association’s Scientific Sessions, revealing that a single dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results